Deep Research & Segment Analysis For Dental Biomaterials Market

Comments · 108 Views

Straumann significantly invests in R&D, sales, and marketing activities to drive innovation and to capture the growth potential in underpenetrated markets. In order to increase its customer base and maintain its position in the market, the company focuses on various growth strategies s

The increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable income are the major factors driving the growth of this market. 

 

Based on type, the dental biomaterials is broadly segmented into metallic, ceramic, polymeric, metal-ceramic, and natural biomaterials. In 2018, the metallic biomaterials segment accounted for the largest share of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants and the wide applications of metallic biomaterials in dentistry. 

 

Rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. 

 

For More Information, Get Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=198160556 

 

In 2018, the implantology application segment accounted for the largest share of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants. 

 

Key factors attributed to the large share of dental biomaterials market in Europe are the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants and other dental products, and the growing number of dental hospitals and clinics. 

 

eeff828843e6d9dda4032fc368733c3e.jpg

According to market research report, "Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User - Global Forecast to 2023", The dental biomaterials market is projected to reach USD 9.6 billion by 2023 from an estimated USD 6.7 billion in 2018, at a CAGR of 7.4%.

 

The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).

Comments